American Heart Journal
Volume 153, Issue 1 , Pages 82.e1-82.e11 , January 2007

Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: An analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)

  • Gregg C. Fonarow, MD

      Affiliations

    • Ahmanson-UCLA Cardiomyopathy Center, UCLA Medical Center, Los Angeles, CA
    • Corresponding Author InformationReprint requests: Gregg C Fonarow, MD, Ahmanson-UCLA Cardiomyopathy Center, UCLA Medical Center, 10833 LeConte Avenue, Room 47-123 CHS, Los Angeles, CA 90095-1679.
    • ,
  • William T. Abraham, MD

      Affiliations

    • Division of Cardiology, Ohio State University, Columbus, OH
    • ,
  • Nancy M. Albert, RN, PhD

      Affiliations

    • Division of Nursing and George M and Linda H Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, OH
    • ,
  • Wendy Gattis Stough, PharmD

      Affiliations

    • Department of Medicine, Duke University Medical Center, Durham, NC
    • Department of Clinical Research, Campbell University School of Pharmacy, Research Triangle Park, NC
    • ,
  • Mihai Gheorghiade, MD

      Affiliations

    • Division of Cardiology, Feinberg School of Medicine, Northwestern University, Chicago, IL
    • ,
  • Barry H. Greenberg, MD

      Affiliations

    • Department of Medicine, USCD Medical Center-Hillcrest, University of California, San Diego, CA
    • ,
  • Christopher M. O'Connor, MD

      Affiliations

    • Division of Cardiology, Duke University Medical Center/Duke Clinical Research Institute, Durham, NC
    • ,
  • Jie Lena Sun, MS

      Affiliations

    • Duke Clinical Research Institute, Durham, NC
    • ,
  • Clyde Yancy, MD

      Affiliations

    • Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, TX
    • ,
  • James B. Young, MD

      Affiliations

    • Department of Cardiovascular Medicine, Heart Failure Section, Cleveland Clinic Foundation, Cleveland, OH
    • ,
  • on behalf of the OPTIMIZE-HF Investigators and Coordinators

Received 1 August 2006 ,Accepted 11 October 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The OPTIMIZE-HF registry is registered: http://www.clinicaltrials.gov, study number NCT00344513 and was funded by GlaxoSmithKline.

PII: S0002-8703(06)00892-1

doi: 10.1016/j.ahj.2006.10.008

American Heart Journal
Volume 153, Issue 1 , Pages 82.e1-82.e11 , January 2007

Article Tools

* Image Usage & Resolution